Show simple item record

Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

dc.contributor.authorStevens, Lindsey
dc.contributor.authorArdeshna, Kirit M.
dc.contributor.authorQian, Wendi
dc.contributor.authorSmith, Paul
dc.contributor.authorBraganca, Nivette
dc.contributor.authorLowry, Lisa
dc.contributor.authorPatrick, Pip
dc.contributor.authorWarden, June
dc.contributor.authorPocock, Christopher F. E.
dc.contributor.authorLinch, David C.
dc.contributor.authorBradstock, Ken
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.authorWalewski, Jan
dc.contributor.authorStephens, Richard
dc.contributor.authorJack, Andrew
dc.contributor.authorDavies, John
dc.contributor.authorCunningham, David
dc.contributor.authorMiall, Fiona
dc.date.accessioned2021-03-04T10:59:44Z
dc.date.available2021-03-04T10:59:44Z
dc.date.issued2014
dc.identifier.citationArdeshna K. M. , Qian W., Smith P., Braganca N., Lowry L., Patrick P., Warden J., Stevens L., Pocock C. F. E. , Miall F., et al., "Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial", LANCET ONCOLOGY, cilt.15, sa.4, ss.424-435, 2014
dc.identifier.issn1470-2045
dc.identifier.othervv_1032021
dc.identifier.otherav_70083884-a790-47ac-938f-2675b4c905a9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/77257
dc.identifier.urihttps://doi.org/10.1016/s1470-2045(14)70027-0
dc.description.abstractBackground Patients with advanced-stage, low-tumour-burden follicular lymphoma have conventionally undergone watchful waiting until disease progression. We assessed whether rituximab use could delay the need for chemotherapy or radiotherapy compared with watchful waiting and the effect of this strategy on quality of life (QoL).
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.titleRituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
dc.typeMakale
dc.relation.journalLANCET ONCOLOGY
dc.contributor.departmentUniversity College London Hospitals NHS Foundation Trust , ,
dc.identifier.volume15
dc.identifier.issue4
dc.identifier.startpage424
dc.identifier.endpage435
dc.contributor.firstauthorID214155


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record